Avoid common mistakes on your manuscript.
Dear Reader,
Welcome to the final issue of BioDrugs for 2021.
I wish to reflect on this year’s achievements, and to thank all those who have contributed their time and effort to guarantee the quality of the content published in the journal.
The high quality of content published in BioDrugs has been reflected in the most recent Impact Factor of 5.807 and CiteScore™ of 9.40. These place the journal in the first quartile for Pharmacology & Pharmacy in Clarivate Analytics, and 13th of 246 journals (94th percentile) in Medicine – Pharmacology in Scopus. Further, BioDrugs has published content in a timely manner, with an average time from submission to acceptance of 86 days in 2021.
In 2021, over 48 articles have been published. The most popular of these in terms of downloads from SpringerLink have been:
Social media sharing and other online mentions of information are other metrics with which to measure the reach of articles. This year the following articles published in BioDrugs scored highly on the Altmetric system:
The COVID-19 pandemic has continued to present many challenges and I would like to thank all who have contributed to ensuring the journal has thrived despite the ongoing issues. Springer Nature has continued to support the global response to COVID-19 by making all relevant content immediately and freely available.
I would like to start by thanking the authors of the articles published in BioDrugs over the course of 2021. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success.
The quality of published articles is also testament to the diligence of the peer reviewers. I would like to acknowledge the following individuals who acted as reviewers for BioDrugs in the last 12 months:
Mohammed I. Aladul, Iraq
Saja Alnahar, Jordan
Luca Antonioli, Italy
Kazuhiro Araki, Japan
Jon E. Arnason, USA
Raja Atreya, Germany
Yves Aubin, Canada
Albert J. Augustin, Germany
Sathy Balu-Iyer, USA
Liese Barbier, Belgium
Alain Beck, France
Shubha Bhat, USA
Francisco J. Blanco, Spain
Challice Bonifant, USA
Enrico Borrelli, Italy
John Botson, USA
Melissa Bowerman, UK
Jason Braithwaite, USA
Vitalis Briedis, Lithuania
Joseph Bubalo, USA
Myrna Candelaria, Mexico
Kuan Rong Chan, Singapore
Siew Eng Choon, Malaysia
Christos Chouaïd, France
Beth Christian, USA
Laura C. Coates, UK
Arnon D. Cohen, Israel
Hillel P. Cohen, USA
Pier Conte, Italy
Esteban Cruz, Australia
Paola M. Cutroneo, Italy
Dimitrios Daoussis, Greece
Fernando de Mora, Spain
Joshua Drago, USA
Erwin Dreesen, Belgium
Niklas Ekman, Finland
Federica Facciotti, Italy
Napoleone Ferrara, USA
Josef Finsterer, Austria
Regina Folster-Holst, Germany
Massimo Franchini, Italy
Marco Franzetti, Italy
Egidio Freitas, Portugal
Inbar Friedrich Ben-Nun, USA
John P. Gabrielson, USA
Paul Gamlin, USA
Dayong Gao, USA
Roman Gardlik, Slovakia
Pere Gascon, Spain
Xin Ge, USA
Salah Ghabri, France
Clemens Giessen-Jung, Germany
Bente Glintborg, Denmark
Miguel Ángel Gonzalez-Gay, Spain
Boris Gorovits, USA
John Gubatan, USA
Luisa Guidi, Italy
Lora Hamuro, USA
Graham F. Hatfull, USA
Michael R. Hayden, Canada
Michael Hickey, Australia
Joachim Hombach, Switzerland
Xucheng Hou, USA
Li-feng Hsu, Taiwan, Republic of China
Huei-Kai Huang, Taiwan, Republic of China
Allison Hubel, USA
Jessica Jalbert, USA
Naoko Kanda, Japan
Tae Hyun Kang, Republic of Korea
Seoyoung C. Kim, USA
Masahiro Kino-oka, Japan
Allison Kolbe, USA
Hans-Christian Kolberg, Germany
Emanuela Lacana, USA
Edward Chia-Cheng Lai, Taiwan, Republic of China
Augustin Latourte, France
Mark G. Lebwohl, USA
Howard Lee, Republic of Korea
David S. Liao, USA
Michael N. Liebman, USA
Ruth Lopert, USA
Xiao-Yong Man, China
Kenneth K.C. Man, UK
Marco Matucci-Cerinic, Italy
Matthew Mei, USA
Julie Meneghel, UK
Phillip Minar, USA
Lotte Minnema, The Netherlands
Thameez Mohammed Koyasseril Yehiya, USA
Thallachallour Mohanakumar, USA
Serafin Morales, Spain
Michael Morgan, Germany
Diane R. Mould, USA
Asuka Nanbo, Japan
Kyle O'Donnell, USA
Michael O'Dwyer, Ireland
Sonia T. Oskouei, USA
Konstantinos Papamichael, USA
Friedemann Paul, Germany
Jean-Phillipe Pellois, USA
Edith Pfister, USA
Stefano Piaserico, Italy
Diana P. Pires, Portugal
Elizabeth Price, UK
Varun K. Ranpariya, USA
Emanuel Raschi, Italy
Aymeric Ravel-Chapuis, Canada
Soledad Retamozo, Argentina
Kelly A. Reynolds, USA
Wolfgang F. Richter, Switzerland
Remy Robert, Australia
Giuseppe Roberto, Italy
Carlos A.V. Rodrigues, Portugal
Philip J. Rosenfeld, USA
Antonia P. Sagona, UK
Hironaga Satake, Japan
Martin Schiestl, Austria
Martin Schmelz, Germany
Giulia Scondotto, Italy
Ivana Stojanovic, Serbia
Kangho Suh, USA
Janet Sultana, Malta
Sasha Taleban, USA
Stephen J. Thomas, USA
Tiago Torres, Portugal
Tsen-Fang Tsai, Taiwan, Republic of China
Christopher J. Twelves, UK
Niels Vande Casteele, USA
Bram Verstockt, Belgium
Pablo Villoslada, Spain
Gianni Virgili, Italy
Philip Vlummens, Belgium
Arnold G. Vulto, The Netherlands
Norihiro Watanabe, USA
Keith Watson, UK
Christopher Webster, USA
Martina Weise, Germany
Valdemar Wendelboe Nielsen, Denmark
Astrid Wiens, Brazil
Edward Wild, UK
Elena Wolff-Holz, Germany
Charles C. Wykoff, USA
Toshinari Yamashita, Japan
Wei Zhang, China
Haiyan Zhou, UK
Zsombor Zrubka, Hungary
I am also very grateful to the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes.
Lothar Bergmann, Klinikum der Johann Wolfgang Goethe-Universitat, Frankfurt, Germany
George D. Demetri, Dana Farber Cancer Institute, Boston, MA, USA
Terence R. Flotte, University of Massachusetts Medical School, Worcester, MA, USA
Timothy M. Ganey, Vivex Biomedical, Atlanta, GA, USA
Arnold Ganser, Hannover Medical School, Hannover, Germany
Hans-Peter Gerber, 3T Biosciences, Palo Alto, CA, USA
Thijs J. Giezen, Foundation Pharmacy for Hospitals in Haarlem, Haarlem, Netherlands
Bernd Groner, Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt, Germany
Francois Guilhot, Université de Poitiers, Poitiers, France
William H. Hildebrand, University of Oklahoma, Oklahoma City, OK, USA
Phillippe Moingeon, Servier Pharmaceuticals, Paris, France
Dafne Müller, Universitat Stuttgart, Stuttgart, Germany
Won Park, Inha University Medical School, Incheon, Republic of Korea
Cesar Picado, Hospital Clinic, Universitat de Barcelona, Barcelona, Spain
Thomas Schirrmann, YUMAB GmbH, Braunschweig, Germany
Susan Sharfstein, SUNY Polytechnic Institute, Albany, NY, USA
Cy A. Stein, City of Hope Medical Center, Duarte, CA, USA
Raymond C. Stevens, University of Southern California, Los Angeles, CA, USA
William R. Strohl, BiStro Biotech Consulting, Bridgewater, NJ, USA
Bruce A. Sullenger, Duke University Medical Center, Durham, NC, USA
Jonathan Terrett, CRISPR Therapeutics, Inc., Cambridge, MA, USA
Gianluca Trifirò, University of Verona, Verona, Italy
Piotr Trzonkowski, Medical University of Gdansk, Gdansk, Poland
Jos W. van der Meer, Radboud University Medical Center, Nijmegen, The Netherlands
Gillian Woollett, Avalere Health, Washington, DC, USA
In terms of other important company initiatives, the Springer Nature ‘Sustainable Development Goals (SDG) Programme’ is aiming to connect researchers who are tackling the world’s toughest challenges with practitioners in policy and business, while the ‘Women in Science’ initiative aims to help empower more women scientists to achieve scientific excellence. Finally, I am delighted to inform you that Springer Nature is now carbon neutral for its direct operations (offices, fleet and flights) and earlier this year signed The Climate Pledge, making a commitment to be Net Zero carbon by 2040.
Returning to BioDrugs, the editorial program for 2022 is well under way, and I am looking forward to bringing you many high-quality and authoritative articles in the field of biotechnology-based pharmaceuticals over the coming year.
I thank you for your continued support.
With best wishes,
Kathy Fraser, Editor
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. BioDrugs 35, 589–592 (2021). https://doi.org/10.1007/s40259-021-00506-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40259-021-00506-6